Real-World Treatment of mCRPC
Recent studies reveal how newer mCRPC therapies work and are being used in routine clinical practice.
Diagnosis & Disease Information
Cancers, Viruses, and the Evolution of Fear
In The Emperor of All Maladies: A Biographic of Cancer, the oncologist Siddhartha Mukherjee, MD, intuits, “Down to their innate molecular core, cancer cells are hyperactive, survival-endowed, scrappy, fecund, inventive copies of ourselves.”1 Replace “cancer cells” with “viruses” and the quote holds equally true. Darwinian perpetrators of genomic dysregulation, many viruses have integrated foundationally into…
Dialysis Facilities Confront COVID-19
Dialysis facilities have stepped up precautions to protect patients with kidney failure from COVID-19, which can cause severe respiratory illness and death.
Managing Implicit Bias May Address Healthcare Disparities
Unconscious, unacknowledged thoughts and feelings may interfere with fair and objective evaluations of different groups of people.
Intermittent Enzalutamide Dosing for mCRPC Probed
In a small study, intermittent vs continuous dosing was associated with improved overall survival and prolonged time on treatment.
Patient Lawsuits for HIPAA-Related Breaches
HIPAA-related lawsuits came to the attention of Alexander Wolff when a fellow attorney called him with a case a few years ago. The plaintiff was a woman and friend of a man who was dating a nurse. The nurse, who worked at a hospital where the plaintiff received healthcare, was suspicious that the plaintiff and…
Kidney Cancer Risk Tied to Body Size in Early Life
Early life body size, including birth weight and overweight, may predict a person’s risk of renal cell carcinoma (RCC) as adults, according to investigators. “Our findings indicate that RCC may originate earlier in life than previously thought and suggest that new explorations into the mechanisms underlying these associations should be undertaken,” a team led by…
Dialysis Modalities Found to Offer Similar Survival
Patients starting on peritoneal dialysis or in-center hemodialysis have similar mortality risks, according to a new systematic review and meta-analysis of studies using propensity score matching to compare mortality risks between the modalities.
- Loading...
Loading...
Next post in Hemodialysis
Loading... 
Loading...